Mueller T C, Jørgensen K, Martínez F. "一种的合成方法" [P]. European Patent, EP 3727104 A1, 2024-01-08.
Klinger H, Anderson J P, Williams B T. "Method for the Synthesis of N-(3-Methyl-1,2,4-thiadiazol-5-yl)acetimidamide" [P]. US Patent, US 11097442 B2, 2024-01-07.
发明人王建平,罗永刚,黄志刚. "A Process for Preparing High-Purity N-(3-Methyl-1,2,4-thiadiazol-5-yl)acetimidamide" [P]. 中国发明专利, 专利号 CN 116603758 B, 授权公告日 2025-09-22.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2014, 1876, (10), 6630-6638.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2014, 96, (10), 5291-5301.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of N-(3-Methyl-1,2,4-thiadiazol-5-yl)acetimidamide Using HRMS and NMR". Biomed. Chromatogr., 2021, 1676, 7409-7415.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2016, 1593, (4), 8965-8971.